-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] In recent years, driven by the wave of intelligence, a large number of pharmaceutical industry companies have begun to accelerate the promotion of intelligent transformation
.
For example, in 2021, Benxi Sanyao will invest 40 million yuan to carry out intelligent transformation in the production field
.
The transformation at this stage is mainly the digital management of the manufacturing process in the preparation workshop
.
The pharmaceutical industry is pushing for intelligent transformation (Source: Pharmaceutical Network) According to the relevant person in charge of the company, in the past, the production process had to be adjusted manually for moisture, temperature and pressure, and each batch of products had slight differences
.
Now the intelligent transformation is undergoing big data collection.
By the end of this year, through further debugging and operation, the digital transformation of the preparation workshop will achieve ideal results
.
At that time, it will be upgraded from the stage of data collection to the stage of integrated analysis of data and precise control of data to ensure that products are infinitely close to uniformity, and the quality and quality of products are more stable
.
In fact, since the beginning of this year, Liaoning China Resources Benxi Sanyao has achieved a "good start" in production and operation with the help of intelligence.
The sales revenue in the first two months reached 85 million yuan, a year-on-year increase of 7%; profits, taxes and profits increased year-on-year respectively.
8% and 6%
.
Another pharmaceutical company, Qi Rui Pharmaceutical, also said that the company is making every effort to promote intelligent transformation, and the improvement of production capacity and management capacity has been obvious
.
It is understood that before the transformation, the drug production of Qirui Pharmaceuticals mainly adopted the batch production mode of stand-alone equipment.
The semi-finished product transfer mainly relies on manual operation, the degree of automation is not high, and basically no information technology is used
.
After the transformation, Qirui Pharmaceutical has realized the transformation from stand-alone production to online production, as well as continuous production in the future, saving labor costs, reducing the risk of product contamination, and realizing the traceability management of products and their quality.
.
Take "light inspection", an important part of the production of freeze-dried powder injection preparations as an example.
Previously, the semi-finished products after capping had to be manually moved and placed on the light inspection table for manual inspection.
System, automatic light inspection machine and capping machine are linked, reducing at least 6 operators, and also reducing the risk of confusion during batch switching
.
From the above point of view, through the implementation of intelligent transformation, pharmaceutical companies can achieve cost reduction and efficiency improvement, which has become an important starting point for promoting the high-quality development of the pharmaceutical industry
.
The industry said that in the future, big data intelligence will lead innovation-driven development, and the transformation of traditional pharmaceutical companies to intelligent factories and smart medical care has become a major trend
.
In the era of intelligence, pharmaceutical companies can only fly higher and farther with intelligent "wings"
.
It is worth noting that pharmaceutical equipment is an important means of pharmaceutical production, which represents the level of production in the pharmaceutical industry and affects the improvement of drug quality
.
Therefore, under the background of the current pharmaceutical industry's push for intelligent transformation, the industry generally believes that the degree of intelligence of pharmaceutical equipment will also receive more and more attention from pharmaceutical companies
.
According to the author's understanding, in fact, China's pharmaceutical equipment industry is currently accelerating the process of upgrading and transformation.
For example, domestic pharmaceutical equipment companies such as Tofflon, Chutian Technology and Canaan Technology have been steadily increasing their R&D investment in product intelligence
.
While product performance continues to improve, business is also moving towards a multi-category, intelligent overall solution provider
.
Taking Canaan Technology as an example, as the development of intelligent manufacturing gradually becomes a trend, it is accelerating the transformation from "manufacturing" to "intelligent manufacturing".
In the second half of 2021, its intelligent medical equipment manufacturing project with a total investment of 1 billion yuan will be Three standardized production workshops have been completed, and the rest are progressing in an orderly manner, and it is planned to be completed in 2023
.
The author learned that the project is mainly aimed at the core areas of the health industry such as granulation and whole line equipment, solid preparation equipment, etc.
After it is put into operation, it can achieve an annual output of 4,000 sets of high-end pharmaceutical equipment, and the output value of the enterprise will increase by 5 times
.
In general, intelligence is bringing changes to pharmaceutical production, and the pharmaceutical equipment industry has become the general trend of the industry from "manufacturing" to "intelligent manufacturing"
.
The industry predicts that in the future, with the continuous upgrading of the intelligentization of the pharmaceutical industry, the pharmaceutical equipment industry will also usher in huge changes, and with the help of automated and intelligent products, it will further help pharmaceutical companies achieve cost reduction and efficiency enhancement, intelligent and green transformation
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
For example, in 2021, Benxi Sanyao will invest 40 million yuan to carry out intelligent transformation in the production field
.
The transformation at this stage is mainly the digital management of the manufacturing process in the preparation workshop
.
The pharmaceutical industry is pushing for intelligent transformation (Source: Pharmaceutical Network) According to the relevant person in charge of the company, in the past, the production process had to be adjusted manually for moisture, temperature and pressure, and each batch of products had slight differences
.
Now the intelligent transformation is undergoing big data collection.
By the end of this year, through further debugging and operation, the digital transformation of the preparation workshop will achieve ideal results
.
At that time, it will be upgraded from the stage of data collection to the stage of integrated analysis of data and precise control of data to ensure that products are infinitely close to uniformity, and the quality and quality of products are more stable
.
In fact, since the beginning of this year, Liaoning China Resources Benxi Sanyao has achieved a "good start" in production and operation with the help of intelligence.
The sales revenue in the first two months reached 85 million yuan, a year-on-year increase of 7%; profits, taxes and profits increased year-on-year respectively.
8% and 6%
.
Another pharmaceutical company, Qi Rui Pharmaceutical, also said that the company is making every effort to promote intelligent transformation, and the improvement of production capacity and management capacity has been obvious
.
It is understood that before the transformation, the drug production of Qirui Pharmaceuticals mainly adopted the batch production mode of stand-alone equipment.
The semi-finished product transfer mainly relies on manual operation, the degree of automation is not high, and basically no information technology is used
.
After the transformation, Qirui Pharmaceutical has realized the transformation from stand-alone production to online production, as well as continuous production in the future, saving labor costs, reducing the risk of product contamination, and realizing the traceability management of products and their quality.
.
Take "light inspection", an important part of the production of freeze-dried powder injection preparations as an example.
Previously, the semi-finished products after capping had to be manually moved and placed on the light inspection table for manual inspection.
System, automatic light inspection machine and capping machine are linked, reducing at least 6 operators, and also reducing the risk of confusion during batch switching
.
From the above point of view, through the implementation of intelligent transformation, pharmaceutical companies can achieve cost reduction and efficiency improvement, which has become an important starting point for promoting the high-quality development of the pharmaceutical industry
.
The industry said that in the future, big data intelligence will lead innovation-driven development, and the transformation of traditional pharmaceutical companies to intelligent factories and smart medical care has become a major trend
.
In the era of intelligence, pharmaceutical companies can only fly higher and farther with intelligent "wings"
.
It is worth noting that pharmaceutical equipment is an important means of pharmaceutical production, which represents the level of production in the pharmaceutical industry and affects the improvement of drug quality
.
Therefore, under the background of the current pharmaceutical industry's push for intelligent transformation, the industry generally believes that the degree of intelligence of pharmaceutical equipment will also receive more and more attention from pharmaceutical companies
.
According to the author's understanding, in fact, China's pharmaceutical equipment industry is currently accelerating the process of upgrading and transformation.
For example, domestic pharmaceutical equipment companies such as Tofflon, Chutian Technology and Canaan Technology have been steadily increasing their R&D investment in product intelligence
.
While product performance continues to improve, business is also moving towards a multi-category, intelligent overall solution provider
.
Taking Canaan Technology as an example, as the development of intelligent manufacturing gradually becomes a trend, it is accelerating the transformation from "manufacturing" to "intelligent manufacturing".
In the second half of 2021, its intelligent medical equipment manufacturing project with a total investment of 1 billion yuan will be Three standardized production workshops have been completed, and the rest are progressing in an orderly manner, and it is planned to be completed in 2023
.
The author learned that the project is mainly aimed at the core areas of the health industry such as granulation and whole line equipment, solid preparation equipment, etc.
After it is put into operation, it can achieve an annual output of 4,000 sets of high-end pharmaceutical equipment, and the output value of the enterprise will increase by 5 times
.
In general, intelligence is bringing changes to pharmaceutical production, and the pharmaceutical equipment industry has become the general trend of the industry from "manufacturing" to "intelligent manufacturing"
.
The industry predicts that in the future, with the continuous upgrading of the intelligentization of the pharmaceutical industry, the pharmaceutical equipment industry will also usher in huge changes, and with the help of automated and intelligent products, it will further help pharmaceutical companies achieve cost reduction and efficiency enhancement, intelligent and green transformation
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
